Vascular endothelial growth factor

December 16, 2009

Lucentis: Another Shot in the Eye, Effective TX for ARMD

Lucentis is the second anti-VEGF drug FDA approved for the treatment of wet macular degeneration. It is an effective treatment for wet macular degeneration. The formulation differs from Macugen and Avastin as do the visual results.
January 8, 2010

Blood in the Eye: You Make the Call

I had a patient with sudden loss of vision. He has diabetes and I diagnosed a vitreous hemorrhage. What are the causes and possible treatments?
January 27, 2010

Avastin: An Adjunctive Therapy for Proliferative Diabetic Retinopathy

Pan-retinal laser photocoagulation has been the gold-standard treatment for proliferative diabetic retinopathy. Avastin injections may become a safer, better alternative to retinal laser treatment to prevent blindness.
February 15, 2010

Neovascularization Causes Blindness

Neovascularization develops in both macular degeneration and diabetic retinopathy. It is the neovascular tissue, or abnormal blood vessels, that causes blindness and is mediated by VEGF.